We are live on !
Find out more
Moors & Cabot Portfolio holdings
AUM
$2.65B
Turnover
11.39%
1-Year Est. Return
29.91%
Moors & Cabot is a full-service wealth management firm that dates to 1890, when John F. Moors and Charles Cabot started it in Boston. The two founders set it up to manage their own families' investments and those of their friends. It offers investment management, planning and advice for major life events, and runs its own insurance and annuities department. Michael Hildreth, its president and chief executive, is also one of its owners.
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+29.91%
3 Year Est. Return
+133.86%
5 Year Est. Return
+167.35%
10 Year Est. Return
+483.58%
AUM
$2.65B
AUM Growth
+$76.1M
(+3%)
Cap. Flow
+$62.2M
Cap. Flow % of AUM
Cap. Flow %
2.35%
Top 10 Holdings %
Top 10 Hldgs %
25.91%
Holding
1,027
New
66
Increased
457
Reduced
386
Closed
51
Avg Time Held
Equity + Options
5.2
years
Top 10 Avg Time Held
Equity + Options
4.1
years
Top 20 Avg Time Held
Equity + Options
4.9
years
Avg Time Held Equity only
5.2
years
Top 10 Avg Time Held Equity only
4.1
years
Top 20 Avg Time Held Equity only
4.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$5.66M |
| 2 |
Advanced Micro Devices
AMD
|
+$4M |
| 3 |
Eli Lilly
LLY
|
+$3.85M |
| 4 |
Boston Scientific
BSX
|
+$3.28M |
| 5 |
Apple
AAPL
|
+$2.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3.9M |
| 2 |
Qiagen
QGEN
|
+$3.78M |
| 3 |
iShares US Medical Devices ETF
IHI
|
+$3.7M |
| 4 |
Accenture
ACN
|
+$3.04M |
| 5 |
US Treasury 6 Month Bill ETF
XBIL
|
+$2.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.95% |
| 2 | Miscellaneous | 18.96% |
| 3 | Energy | 10.33% |
| 4 | Financials | 9.12% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
Ameren
AEE
$31.2B
| $421K | 0.02% |
4,232
-284
| -6% | -$30.6K |
2023 Q2
13 quarters
|
|
627
ARK Genomic Revolution ETF
ARKG
$1.96B
| $419K | 0.02% |
7,720
-1,220
| -14% | -$54.9K |
2026 Q1
2 quarters
|
|
628
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$48.5B
| $418K | 0.02% |
4,561
+788
| +21% | +$72.1K |
2025 Q2
5 quarters
|
|
629
Schwab Fundamental US Large Company Index ETF
FNDX
$27.9B
| $416K | 0.02% |
13,222
+1,600
| +14% | +$51.2K |
2026 Q1
2 quarters
|
|
630
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.99B
| $416K | 0.02% |
17,238
+612
| +4% | +$14.8K |
2024 Q2
9 quarters
|
|
631
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.26B
| $415K | 0.02% |
11,790
+2,014
| +21% | +$72.8K |
2025 Q4
3 quarters
|
|
632
iShares Convertible Bond ETF
ICVT
$7.22B
| $413K | 0.02% |
3,661
+883
| +32% | +$102K |
2026 Q1
2 quarters
|
|
633
Baxter International
BAX
$13.3B
| $412K | 0.02% |
17,173
| – | – |
2014 Q1
50 quarters
|
|
634
Axsome Therapeutics
AXSM
$6.96B
| $411K | 0.02% |
2,230
-100
| -4% | -$21.8K |
2025 Q1
6 quarters
|
|
635
Brown & Brown
BRO
$23.9B
| $410K | 0.02% |
6,738
-205
| -3% | -$14.1K |
2020 Q4
23 quarters
|
|
636
WEC Energy
WEC
$38.1B
| $409K | 0.02% |
4,063
+83
| +2% | +$9.04K |
2015 Q3
44 quarters
|
|
637
Omega Healthcare
OHI
$14.7B
| $408K | 0.02% |
8,819
+493
| +6% | +$23.6K |
2025 Q2
5 quarters
|
|
638
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$18B
| $408K | 0.02% |
8,377
+89
| +1% | +$4.46K |
2025 Q3
4 quarters
|
|
639
CRISPR Therapeutics
CRSP
$4.86B
| $408K | 0.02% |
7,373
+641
| +10% | +$34.6K |
2025 Q2
5 quarters
|
|
640
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.29B
| $407K | 0.02% |
+3,851
| New | +$404K |
2026 Q3
0 quarters
|
|
641
Pinnacle Financial Partners Inc
PNFP
$15.2B
| $406K | 0.02% |
+4,342
| New | +$438K |
2026 Q3
0 quarters
|
|
642
Shopify
SHOP
$192B
| $402K | 0.02% |
2,714
+30
| +1% | +$4.07K |
2019 Q2
29 quarters
|
|
643
Citizens Financial Group
CFG
$26.5B
| $399K | 0.02% |
6,250
+502
| +9% | +$35.3K |
2024 Q3
8 quarters
|
|
644
Antero Midstream
AM
$8.97B
| $398K | 0.02% |
19,758
-350
| -2% | -$7.71K |
2022 Q1
18 quarters
|
|
645
abrdn Physical Platinum Shares ETF
PPLT
$1.8B
| $397K | 0.02% |
25,750
+30
| +0.1% | +$469 |
2025 Q2
5 quarters
|
|
646
Regions Financial
RF
$24.1B
| $396K | 0.02% |
14,737
+575
| +4% | +$17.4K |
2014 Q1
50 quarters
|
|
647
Skydance Corporation
SKYD
$40.4B
| $394K | 0.01% |
38,095
+9,060
| +31% | +$88.5K |
2025 Q3
4 quarters
|
|
648
Howmet Aerospace
HWM
$81.8B
| $393K | 0.01% |
1,736
+123
| +8% | +$32.4K |
2025 Q2
5 quarters
|
|
649
iShares 10-20 Year Treasury Bond ETF
TLH
$12.2B
| $391K | 0.01% |
4,244
+868
| +26% | +$84K |
2026 Q1
2 quarters
|
|
650
Biogen
BIIB
$36.7B
| $391K | 0.01% |
1,729
+71
| +4% | +$15.1K |
2025 Q4
3 quarters
|
|
Similar funds
FFH
Moors & Cabot's Q3 2026 Portfolio in Review
As of Q3 2026, Moors & Cabot held 1,027 positions worth $2.65B, up 3% from $2.57B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Moors & Cabot's Q3 2026 filing shows 66 new, 457 increased, 386 reduced and 51 closed positions. Its largest new stake was Vivmark Residential: 28,117 shares worth $1.71M. The largest sale was Micron Technology, an estimated $3.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Energy.
- Moors & Cabot's largest Q3 2026 buy was Vivmark Residential: 28,117 shares worth $1.71M.
- Moors & Cabot added most to GE Vernova in Q3 2026, an estimated $5.66M increase.
- Moors & Cabot's biggest Q3 2026 reduction was Micron Technology, cutting an estimated $3.9M.
- Moors & Cabot fully exited AvalonBay Communities in Q3 2026, selling an estimated $1.85M.
- Moors & Cabot's ten largest holdings make up 26% of its $2.65B portfolio in Q3 2026.
- Moors & Cabot opened 66 new positions and closed 51 in Q3 2026.
- Moors & Cabot's portfolio value rose 3% quarter-over-quarter to $2.65B.
Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.